Cargando…

The Effect of Ethanol on the Release of Opioids from Oral Prolonged-Release Preparations

Recent experience has prompted the US FDA to consider whether ethanol ingestion may modify the release characteristics of prolonged-release formulations, where dose dumping may be an issue for patient safety. The influence of ethanol on the in vitro release of opioid drugs from some prolonged-releas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walden, Malcolm, Nicholls, Fiona A., Smith, Kevin J., Tucker, Geoffrey T.
Formato:	Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409176/ https://www.ncbi.nlm.nih.gov/pubmed/17882730 http://dx.doi.org/10.1080/03639040701377292

Ejemplares similares

1023. A Controlled-Release Prescription Oral Opioid Can Prolong S. aureus Survival in Injection Drug Preparation Equipment and Potentially Increase Bacteremia Risk
por: Kasper, Katherine, et al.
Publicado: (2018)

Effects of Ethanol Concentration on Oral Aroma Release After Wine Consumption
por: Muñoz-González, Carolina, et al.
Publicado: (2019)

Successful Treatment of Opioid Dependence with Flexible Doses of Injectable Prolonged Release Buprenorphine
por: D'Agnone, Oscar
Publicado: (2019)

Increased Treatment Engagement and Adherence: Flexible Management with Prolonged-Release Buprenorphine in Treatment of Opioid Dependence
por: Hard, Bernadette
Publicado: (2021)

Systematic Review of the Safety and Tolerability of Injectable Prolonged-Release Buprenorphine (Buvidal) in Adults With Opioid Dependence
por: Williams, Laura, et al.
Publicado: (2023)

Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis
por: Paridaens, Kristine, et al.
Publicado: (2023)

Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain
por: Steigerwald, Ilona, et al.
Publicado: (2013)

Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers
por: Ait Abdellah, Samira, et al.
Publicado: (2023)

Methodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release
por: Bacallao, Jorge, et al.
Publicado: (2016)

Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers
por: Mick, Inge, et al.
Publicado: (2016)

Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)

Opioid Overdose Prevention Toolkit Released
Publicado: (2013)

Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
por: Phillips-Jackson, Helen, et al.
Publicado: (2020)

Prolonged-Release Buprenorphine Therapy in Opioid Use Disorder Can Address Stigma and Improve Patient Quality of Life
por: Somaini, Lorenzo, et al.
Publicado: (2021)

Preparation of the Potential Ocular Inserts by Electrospinning Method to Achieve the Prolong Release Profile of Triamcinolone Acetonide
por: Mirzaeei, Shahla, et al.
Publicado: (2018)

Preparation and modeling of three‐layered PCL/PLGA/PCL fibrous scaffolds for prolonged drug release
por: Milosevic, Miljan, et al.
Publicado: (2020)

A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk
por: Kasper, Katherine J., et al.
Publicado: (2019)

Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study
por: Palis, Heather, et al.
Publicado: (2022)

Safety profile of prophylactic rescue dosing of immediate-release oral opioids in cancer patients
por: Tanaka, Rei, et al.
Publicado: (2018)

Biocomposite for Prolonged Release of Water-Soluble Drugs
por: Meirelles, Lyghia M. A., et al.
Publicado: (2023)

Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation
por: Lazzari, Marzia, et al.
Publicado: (2016)

Opioid rotation with extended-release opioids: where should we begin?
por: Nalamachu, Srinivas
Publicado: (2011)

Correction: A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk
por: Kasper, Katherine J., et al.
Publicado: (2019)

Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets
por: McLean, Stuart, et al.
Publicado: (2009)

Disentangling the effects of Corticotrophin Releasing Factor and GABA release from the ventral bed nucleus of the stria terminalis on ethanol self-administration in mice
por: C.A., Gianessi, et al.
Publicado: (2023)

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment
por: Mazzeti, Ana Lia, et al.
Publicado: (2023)

Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence
por: Muduma, Gorden, et al.
Publicado: (2014)

Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals
por: Turton, Samuel, et al.
Publicado: (2018)

Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States
por: Iwanicki, Janetta L., et al.
Publicado: (2016)

A review of ropinirole prolonged release in Parkinson’s disease
por: Nashatizadeh, Muhammad M, et al.
Publicado: (2009)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Casein Microgels as Benzydamine Hydrochloride Carriers for Prolonged Release
por: Milenkova, Sofia, et al.
Publicado: (2022)

Preparation and In Vitro/In Vivo Evaluation of Orally Disintegrating/Modified-Release Praziquantel Tablets
por: Wen, Xuemei, et al.
Publicado: (2021)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

Author Correction: Preparation and modeling of three‐layered PCL/PLGA/PCL fibrous scaffolds for prolonged drug release
por: Milosevic, Miljan, et al.
Publicado: (2021)

Opioid modulation of GABA release in the rat inferior colliculus
por: Tongjaroenbungam, Walaiporn, et al.
Publicado: (2004)

In vivo detection of optically-evoked opioid peptide release
por: Al-Hasani, Ream, et al.
Publicado: (2018)

Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Has the Same Effect as Gonadotropin-Releasing Hormone Agonist Injections in Terms of Preparation for Transcervical Resection Myomectomy
por: Ito, Mika, et al.
Publicado: (2022)

Macro- and Nanoscale Effect of Ethanol on Bovine Serum Albumin Gelation and Naproxen Release
por: Sanaeifar, Niuosha, et al.
Publicado: (2022)

Bioavailability of Oniria(®), a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
por: Román Martinez, Manuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_alct40eic6hssv1050k1mrk4lg